Highest-materiality recent filing
REMSleep auditor resigns; company reviewing Q2 2026 financials for possible restatement
Fruci & Associates II resigned as auditor on July 17, 2026; no disagreements cited.
RemSleep Holdings changes control; new management team with restricted powers
1000152403 ONTARIO INC acquired ~80% preferred share control from Roman Wood and ~20% from Anita Michaels via private transactions; assumed ~$300K debt.
Founder Thomas Wood dies; board names Anita Michaels Chairman, Jeffrey Marshall CEO
Founder, Chairman, and CEO Thomas Wood died on Feb. 26, 2026; he was the creator of DeltaWave® Nasal Pillow System.
Remsleep Holdings receives FDA 510(k) clearance for Deltawave CPAP Pillows Interface Mask
FDA granted 510(k) clearance for the Deltawave CPAP Pillows Interface Mask on July 2, 2024.
Remsleep Holdings enters equity line with Quick Capital for up to 300M shares at 70% discount
Purchase agreement allows Remsleep to sell up to $100,000 per put (min $20,000) at 70% of lowest traded price over 15-day valuation period.
Remsleep Holdings enters equity line with Janbella for up to 300M shares at 70% market discount
Purchase agreement with Janbella Group for up to 300M shares over 18 months (maturity Feb 18, 2025).
Company issued 2,000,000 Series C Preferred shares to CEO Thomas Wood for assignment of all IP related to the business.
Remsleep amends 8-K to disclose Russell Bird's resignation was voluntary due to health reasons
Amendment clarifies Russell Bird's resignation (effective June 1, 2023) was voluntary and solely for an extended illness.
Remsleep Holdings Chairman and Officer Russell Bird resigns effective June 1, 2023
Russell Bird resigned all positions including officer and Chairman, effective June 1, 2023.
RemSleep DeltaWave reclassified as implantable by FDA; must resubmit 510K after new testing
FDA reclassified DeltaWave as implantable device; company withdrawing current 510K application.
RemSleep Holdings moves corporate headquarters to Clearwater, Florida
Corporate headquarters relocated to 14175 Icot Boulevard, Suite 300, Clearwater, FL 33760.
RemSleep reports cytotoxicity test failures on DeltaWave cannula; new lab to retest
Two cytotoxicity tests on DeltaWave cannula MD, Angled Adaptor and Flexible Hose failed in early 2022.
On May 7, 2026, the Board accepted the resignations of Jeffrey Todd Marshall as Chief Executive Officer, Anita L. Michaels as Chief Operating Officer and Chairman of the Board, and Roman Israel Wood as President, Treasurer and Secretary. The resignations were effective May 27, 2026.
On May 27, 2026, the Board appointed Teresita Rubio as Treasurer and Chairman of the Board, Sanja Pekovic as President and Chief Executive Officer, and Irina Veselinovic as Secretary, effective May 27, 2026.
On June 1, 2026, the Board accepted the resignation of Sanja Pekovic as President and appointed Peter Downey as the Interim President, effective June 2, 2026.
On May 7, 2026, the Board accepted the resignations of Jeffrey Todd Marshall as Chief Executive Officer, Anita L. Michaels as Chief Operating Officer and Chairman of the Board, and Roman Israel Wood as President, Treasurer and Secretary. The resignations were effective May 27, 2026.
On May 27, 2026, the Board appointed Teresita Rubio as Treasurer and Chairman of the Board, Sanja Pekovic as President and Chief Executive Officer, and Irina Veselinovic as Secretary, effective May 27, 2026.
On May 27, 2026, the Board appointed Teresita Rubio as Treasurer and Chairman of the Board, Sanja Pekovic as President and Chief Executive Officer, and Irina Veselinovic as Secretary, effective May 27, 2026.
On May 7, 2026, the Board accepted the resignations of Jeffrey Todd Marshall as Chief Executive Officer, Anita L. Michaels as Chief Operating Officer and Chairman of the Board, and Roman Israel Wood as President, Treasurer and Secretary. The resignations were effective May 27, 2026.
On June 1, 2026, the Board accepted the resignation of Sanja Pekovic as President and appointed Peter Downey as the Interim President, effective June 2, 2026.
Russell Bird voluntarily resigned all positions in and with Remsleep Holdings, Inc. (the “ Company ”) effective 01 June 2023.
Russell Bird voluntarily resigned all positions in and with Remsleep Holdings, Inc. (the “Company”) effective 01 June 2023.
Max materiality 0.90 · Median 0.78 · Most common event other_material